KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
Status:
Terminated
Trial end date:
2018-10-18
Target enrollment:
Participant gender:
Summary
This study is designed to assess how KPI-121 1% compares to prednisolone acetate in reducing
inflammation after cataract surgery in young children. Approximately half the participants
will receive KPI-121 1% eye drops and the other half will receive prednisolone acetate.